99 results
Page 5 of 5
424B5
e66ri
31 May 19
Prospectus supplement for primary offering
5:23pm
6-K
EX-99.1
ujr0 vv5w
22 May 19
Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update
7:58am
6-K
EX-99.1
wiubdlhzpkdo
16 Apr 19
Current report (foreign)
8:25am
F-3/A
3lwtgp5d
10 Apr 19
Shelf registration (foreign) (amended)
11:46am
F-3
vi1fz moguwc5rf8
28 Mar 19
Shelf registration (foreign)
1:21pm
6-K
EX-99.1
o21n 0im1m6otp8
22 Mar 19
Current report (foreign)
8:00am
6-K
EX-99.1
x3bg3wld
6 Feb 19
Sol-Gel and Perrigo will equally share the gross profits generated from sales of the product
4:01pm
6-K
EX-99.1
7pu3kwrr9j6sog7d5
15 Jan 19
Sol-Gel Technologies Appoints John Vieira as U.S. Head of Commercialization
6:33am
6-K
EX-99.1
z9sj3hrope56m7ydh7s
7 Jan 19
Current report (foreign)
6:32am
6-K
EX-99.1
h8hye0a8u3
26 Dec 18
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program of TWIN for the Treatment of Acne Vulgaris
6:07am
6-K
EX-99.1
dol4rg2 cnj
4 Dec 18
Sol-Gel Technologies Announces Sixth Agreement for a Generic Product Candidate with Perrigo
4:05pm
6-K
EX-99.1
7h87xpmdw
13 Nov 18
Sol-Gel Technologies Reports Third Quarter 2018 Financial Results
4:45pm
6-K
EX-99.1
uz0vuwjxljkl
1 Nov 18
Sol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic
4:04pm
6-K
EX-99.1
2c6lder
15 Aug 18
Sol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo
4:01pm
6-K
EX-99.1
j6tos dre1t9xjve
8 Aug 18
Sol-Gel Technologies Reports Second Quarter 2018 Financial Results
7:05am
6-K
EX-99.1
cr745bce 618w
19 Jun 18
Current report (foreign)
8:54am
6-K
EX-99.1
qk6r n2f7
15 May 18
Sol-Gel Technologies Reports First Quarter 2018 Financial Results
12:00am
20-F
xuv68t53ilfjdmh7kko8
26 Mar 18
Annual report (foreign)
12:00am